
1. mol cell proteomics. 2018 jan;17(1):111-120. doi: 10.1074/mcp.ra117.000088. epub 
2017 oct 27.

a global survey atpase activity plasmodium falciparum asexual blood stages 
and gametocytes.

ortega c(1), frando a(1)(2), webb-robertson bj(3), anderson ln(3), fleck n(1),
flannery el(1), fishbaugher m(1), murphree ta(3), hansen jr(3), smith rd(3),
kappe shi(1)(2), wright at(3), grundner c(4)(2).

author information: 
(1)from ‡center infectious disease research (formerly seattle biomedical 
research institute), seattle, washington 98109.
(2)§department global health, university washington, seattle, washington
98195.
(3)¶biological sciences division, pacific northwest national laboratory,
richland, washington 99352.
(4)from ‡center infectious disease research (formerly seattle biomedical 
research institute), seattle, washington 98109;
christoph.grundner@cidresearch.org.

effective malaria control elimination hyperendemic areas world will
require treatment plasmodium falciparum (pf) blood stage causes
disease well gametocyte stage required transmission from
humans mosquito vector. currently used therapies kill
gametocytes, highly specialized, non-replicating sexual parasite stage. further
confounding next generation drug development pf unknown metabolic 
state gametocyte lack known biochemical activity most
parasite gene products general. here, take systematic activity-based
proteomics approach survey activity large druggable atpase
family replicating blood stage asexual parasites transmissible,
non-replicating sexual gametocytes. atpase activity broadly changes the
transition asexual schizonts sexual gametocytes, indicating altered
metabolism regulatory roles atpases specific lifecycle stage. 
further experimentally confirm existing annotation predict atpase function
for 38 uncharacterized proteins. mapping activity atpases associated
with gametocytogenesis, assign biochemical activity large number of
uncharacterized proteins identify new candidate transmission blocking
targets.

© 2018 american society biochemistry molecular biology, inc.

doi: 10.1074/mcp.ra117.000088 
pmcid: pmc5750841
pmid: 29079720  [indexed medline]

